Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.05 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |